TerminatedPhase 2NCT02212015
Evaluation of Votrient in Angiosarcoma
Studying Angiosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Heidelberg University
- Principal Investigator
- Peter Hohenberger, MD, MDUniversitätsmedizin Mannheim / Heidelberg University
- Intervention
- Pazopanib + Paclitaxel(drug)
- Enrollment
- 26 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2020
Study locations (10)
- Universitätsklinik Graz, Graz, Austria
- Universitätsklinik Wien, Vienna, Austria
- Helios-Klinikum Bad Saarow, Bad Saarow, Germany
- Helios Klinikum Berlin-Buch, Berlin, Germany
- Universitätsklinikum Carl Gustav Carus, Dresden, Germany
- Universitätsklinikum Essen, Essen, Germany
- Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
- Medizinische Hochschule Hannover, Hanover, Germany
- University Medical Center, Mannheim, Germany
- Klinikum der Universität München Campus Großhadern, München, Germany
Collaborators
Universitätsmedizin Mannheim · Helios Klinikum Berlin-Buch · University Hospital Dresden · Universitätsklinikum Hamburg-Eppendorf · University Hospital, Essen · Hannover Medical School · Klinikum der Universitaet Muenchen, Grosshadern · Medical University of Vienna · Medical University of Graz · Medical University Innsbruck · Novartis Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02212015 on ClinicalTrials.govOther trials for Angiosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06898970Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for AngiosarcomaVarun Monga, MBBS
- RECRUITINGPHASE2NCT07007273Pembrolizumab for Advanced Cutaneous Sarcomas Not Including AngiosarcomaH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNCT06715579Cardiac Angiosarcoma International RegistryImmune Oncology Research Institute
- RECRUITINGPHASE2NCT06849986IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)Fudan University
- RECRUITINGPHASE2NCT06673628Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma PatientsNational Cancer Center, Japan
- RECRUITINGPHASE1NCT06440005A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.
- RECRUITINGNCT06375941Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStarsItalian Sarcoma Group
- RECRUITINGNCT06541652A French Multicenter Observational Retrospective Study of Rare Primary Liver CancersFederation Francophone de Cancerologie Digestive